Why it was recalled
Lack of Sterility Assurance
Product description
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
Lot numbers, UPCs & expiration codes
Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.
Where it was sold
Nationwide Within U.S.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0051-2025
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Nov 6, 2024
- FDA report date
- Nov 27, 2024
- Quantity
- 27,560 Syringes
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Tailstorm Health INC
Original FDA data
Every field from FDA enforcement report D-0051-2025, exactly as published.
Show all FDA fields
- City
- Phoenix
- State
- AZ
- Status
- Terminated
- Country
- United States
- Event ID
- 95718
- Address
- 24416 N 19th Ave Ste 200
- Code information
- Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.
- Postal code
- 85085-1400
- Report date
- Nov 27, 2024
- Product type
- Drugs
- Recall number
- D-0051-2025
- Classification
- Class II
- Recalling firm
- Tailstorm Health INC
- Product quantity
- 27,560 Syringes
- Termination date
- Mar 28, 2025
- Reason for recall
- Lack of Sterility Assurance
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
- Distribution pattern
- Nationwide Within U.S.
- Recall initiation date
- Nov 6, 2024
- Initial firm notification
- Letter
- Center classification date
- Nov 18, 2024